Matches 101 - 150 out of 441 < 1 2 3 4 5 6 7 8 9 >
Match Document Document Title
6136327 Stereospecific delivery of a drug using electrotransport  
Preferential delivery via electrotransport of a preferred isomeric form of a pharmaceutically active chiral compound from a mixture of the isomeric forms of said compound is provided. A method of...
6120803 Prolonged release active agent dosage form adapted for gastric retention  
The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of an active agent formulation to a fluid...
6117441 Silicone core long term androgen delivery implant  
This invention features an implantable system for use as a male contraception and as a treatment of benign prostate hypertrophy and other conditions. The implant system includes an implant intended...
6117442 Drug delivery device, especially for the delivery of androgens  
The invention relates to a delivery device for the controlled release of a therapeutically active agent, especially an androgen, over a prolonged period of time, said device including a core...
6103263 Delayed pulse release hydrogel matrix tablet  
The invention provides a delayed-pulse controlled release pharmaceutical tablet having: (a) from 20 to 60 wt. % of a low molecular weight hydroxypropyl cellulose having a number average...
6099862 Oral dosage form for the controlled release of a biguanide and sulfonylurea  
A controlled release pharmaceutical tablet containing antihyperglycemic drug and a hypoglycemic drug that does not contain an expanding or gelling polymer layer and comprising a core containing the...
6096339 Dosage form, process of making and using same  
The invention disclosed pertains to a dosage form comprising an agent formulation comprising drug and pharmaceutical carrier of cooperating particle size and means for dispensing the agent...
6086919 Pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound  
The invention is directed to a pharmaceutical composition which is a combination of the ACE inhibitor ramipril and a calcium antagonist of one of the dihydropyridine type compounds felodipine,...
6082368 Nicotine candy cigarette  
A nicotine candy is provided for consumption in small volumes and in a cigarette shaped package. Each portion of the candy is obtained by removing it from a cigarette shaped package from the end....
6063395 Drug delivery device especially for the delivery of progestins and estrogens  
The invention relates to a delivery device for the controlled release of a therapeutically active agent, especially a progestin or an estrogen, over a prolonged period of time, said device...
6039975 Colon targeted delivery system  
A novel delivery system for targeting drugs to the colon is herein described. The system is a tablet comprised of three parts: 1) an outer enteric coating, 2) an inner semi-permeable polymer...
6036973 Therapy for neurological diseases  
A dosage form is disclosed for administering 10 ng to 1200 mg tacrine to a patient in need of tacrine therapy.
5997902 Ruminal drug delivery device  
The present invention is concerned with improving the delivery of a drug from a ruminal delivery device to give a consistent delivery of drug to the ruminal environment. Thus, the invention is...
5955103 Dosage form comprising antiepileptic drug  
A dosage form is disclosed for delivering an antiepileptic drug, which dosage form comprises a laminated wall for maintaining the integrity of the dosage form and of the antiepileptic drug.
5945125 Controlled release tablet  
A controlled release tablet including a pharmaceutical agent and an excipient. The excipient includes at least about 60% of a water swellable polymer and a lubricant. The water swellable polymer is...
5932249 Budesonide pellets with a controlled released pattern and process for producing the same  
Disclosed are budesonide pellets with a controlled release pattern containing, from the inside to the outside: a) neutral pellets; b) an active principle layer of micronized budesonide and one or...
5922353 Interlocking couplings for osmotic delivery devices  
A delivery system is disclosed for delivering a fluid-sensitive active agent such as a somatotropin, or an analogue or derivative thereof, to an animal such as a bovine. The delivery system...
5914131 Hydromorphone therapy  
A hydromorphone composition, a hydromorphone dosage form and a method for administering hydromorphone are disclosed, indicated for the management of pain.
5910321 Multiple flow path device for oral delivery of discrete units  
The present invention is directed to an oral active agent delivery system and method for delivering discrete units of an active agent to a patient. An elongate tubular member having first and...
5902605 Drug delivery device with minimal residual drug retention  
The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial...
5897878 Method for administering steroid  
A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the...
5888534 Controlled release of drugs delivered by sublingual or buccal administration  
A composition providing a relatively slow release of water-soluble drugs, such as apomorphine, for delivery via the sublingual or buccal routes.
5882682 Controlled release simvastatin delivery device  
Controlled delivery of a beneficial agent in a dispersion is provided using (i) a compressed core which contains the beneficial agent, a polymer which forms gelatinous microscopic particles upon...
5876750 Effective therapy for epilepsies  
A dosage form is disclosed for delivering an antiepileptic drug, which dosage form comprises a laminated wall for maintaining the integrity of the dosage form and of the antiepileptic drug.
5876752 Use of interfacially-polymerized membranes in delivery devices  
Devices for controlled release of active substances in the form of tablets, capsules and beads comprised of a porous substructure surrounded by one or more interfacial membranes.
5869097 Method of therapy comprising an osmotic caplet  
An osmotic caplet is disclosed comprising an osmotic caplet exit for delivering a preselected dose of drug to a patient in need of therapy.
5869096 Oral osmotic device with hydrogel driving member  
An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably...
5866164 Composition and dosage form comprising opioid antagonist  
A composition of matter is disclosed and claimed comprising an opioid antagonist and a high molecular weight poly(alkylene) or a poly(carboxymethylcellulose). A dosage form is disclosed and claimed...
5858388 Subcutaneous implant for delivery of hydromorphone  
A non-abusable, non-inflammatory, biocompatible, non-biodegradable, subcutaneous, polymeric implant for the prolonged, controlled release of hydromorphone with near zero-order kinetics is...
5858407 Method for administering tandospirone  
A dosage form is provided for administering a drug of the formula ##STR1## to a patient to produce an anxiolytic benefit in the patient. A method is provided for administering the drug of the...
5842476 Method for controlling fertility  
An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a...
5840335 System for the controlled release of active agents and a process for its preparation  
A system for the controlled release of an active agent to an environment of use, said system having a predetermined release rate of the active agent to the environment of use, comprising: a) a...
5830501 Dosage form comprising hydrophilic polymer  
A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the...
5830502 Injection-molded dosage form  
A dosage form is disclosed comprising an injection-molded housing member free of organic solvents.
5827538 Osmotic devices having vapor-permeable coatings  
An osmotic device that, following the imbibement of water vapor, provides for the controlled release of a beneficial agent to an aqueous environment. The device comprises a hydrophilic formulation...
5824341 Composition providing selective release of an active ingredient  
A composition that ensures selective release of an active ingredient at a given site, and in particular, a pharmaceutical composition enabling selective release of an active ingredient to be...
5817340 Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide  
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a therapeutically effective amount of guanidinothiazole compound; and a...
5817335 Osmotic device with high drug loading and delayed activation of drug delivery  
The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial...
5811122 Hide/polymer and leather/polymer composite materials formed by in situ polymerization of polymer precursors impregnated into hide and leather  
Hide/leather-polymer composite materials are provided by the impregnation of polymer systems into interstitial void spaces in the collagen fiber network of the hide/leather precursors, providing a...
5799439 Protective enclosures for seeds  
Protective enclosures for seeds provide a self-contained environment for protecting the seeds in their early growth stages in arid or hostile environments. A protective enclosure (10) for one or...
5798119 Osmotic-delivery devices having vapor-permeable coatings  
An osmotic device that, following the imbibition water vapor, provides for the controlled release of a beneficial agent to a non-aqueous environment. The device comprises a hydrophilic formulation...
5795591 Osmotic drug delivery devices with hydrophobic wall materials  
Osmotically driven drug delivery devices with walls of porous hydrophobic material as the sole diffusion-limiting wall component are disclosed. Despite pores which are considerably larger than the...
5792471 Dispensing devices powered by hydrogel  
This invention relates to devices useful for the controlled delivery of one or more beneficial agents to an environment of use. More specifically, this invention concerns such devices which are...
5785994 Method for administering drug to gastrointestinal tract  
A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The...
5783213 Osmotic membrane and delivery device  
The present invention relates to an improvement in an osmotic delivery device wherein the device comprises a semipermeable wall comprising cellulose acetate butyrate and surrounding an internal...
5776493 Oral osmotic device for delivery of nystatin with hydrogel driving member  
An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably...
5736159 Controlled release formulation for water insoluble drugs in which a passageway is formed in situ  
A controlled release pharmaceutical tablet is disclosed which is based on: (a) a compressed core which contains: (i) a medicament; (ii) at least 23% to 55% by weight, based on the total...
5731001 Locking couplings for osmotic delivery devices  
A delivery system is disclosed for delivering a fluid-sensitive active agent such as a somatotropin, or an analogue or derivative thereof, to an animal such as a bovine. The delivery system...
5728396 Sustained delivery of leuprolide using an implantable system  
The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber...
5718700 Exit means in dosage form  
A dosage form is disclosed comprising a wall that surrounds a bilayer core with exit passageway for communicating with the bilayer core in the wall.
Matches 101 - 150 out of 441 < 1 2 3 4 5 6 7 8 9 >